Skip to main content
Vaishali Pharma Limited logo

Vaishali Pharma Limited — Investor Relations & Filings

Ticker · VAISHALI ISIN · INE972X01022 LEI · 335800LHHVE3JLLKP681 National Stock Exchange of India Wholesale and retail trade
Filings indexed 428 across all filing types
Latest filing 2025-02-06 Regulatory Filings
Country IN India
Listing National Stock Exchange of India VAISHALI

About Vaishali Pharma Limited

https://www.vaishalipharma.com/

Vaishali Pharma Limited specializes in the sourcing, marketing, and distribution of a comprehensive range of healthcare products. The company’s portfolio encompasses Active Pharmaceutical Ingredients (APIs), finished formulations in various dosage forms such as tablets and injectables, and surgical supplies. It also provides veterinary products, herbal supplements, and nutraceuticals. The business model focuses on integrated supply chain management, facilitating the movement of medical products from manufacturing units to global markets. By adhering to international quality standards and leveraging an extensive distribution network, the company serves diverse therapeutic requirements. Its operations emphasize reliability in procurement and the delivery of cost-effective healthcare solutions to a global clientele across multiple regions, including Africa, Asia, and Latin America.

Recent filings

Filing Released Lang Actions
Integrated Filing- Financial
Regulatory Filings
2025-02-06 English
Financial Result Updates
Regulatory Filings
2025-02-06 English
Outcome of Board Meeting
Regulatory Filings
2025-02-06 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-01-31 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a notification to the stock exchange about an upcoming Board Meeting scheduled to approve the Un-Audited Financial Results for the third quarter ended December 31, 2024. It is an intimation letter, not the actual financial report or results. The document is short (1531 characters) and serves to inform about the meeting date and agenda, with the results to be sent after the meeting. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not contain actual financial data or the report itself.
2025-01-31 English
Appointment
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to the National Stock Exchange of India regarding the appointment of a new independent director to the company's board. It references Regulation 30 of the SEBI Listing Regulations, which pertains to disclosures about changes in directors or key managerial personnel. The content includes detailed information about the appointee, the date of appointment, and the approval process. There are no financial statements, earnings data, or report attachments. The document is clearly an announcement of a board/management change rather than a full report or other filing type.
2025-01-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.